β-Interleukin I (163-171), human structure
|
Common Name | β-Interleukin I (163-171), human | ||
---|---|---|---|---|
CAS Number | 106021-96-9 | Molecular Weight | 1004.99000 | |
Density | 1.419g/cm3 | Boiling Point | 1682.6ºC at 760mmHg | |
Molecular Formula | C39H64N12O19 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 971.4ºC |
Use of β-Interleukin I (163-171), humanβ-Interleukin I (163-171), human, an immunostimulatory fragment of human IL-1β peptide, is a T cell activator. β-Interleukin I (163-171), human is not an IL-1R-binding domain of IL-1β. β-Interleukin I (163-171), human is a potent adjuvant that enhances the immune response in a variety of exptl. situations[1][3][4]. |
Name | val-gln-gly-glu-glu-ser-asn-asp-lys |
---|---|
Synonym | More Synonyms |
Description | β-Interleukin I (163-171), human, an immunostimulatory fragment of human IL-1β peptide, is a T cell activator. β-Interleukin I (163-171), human is not an IL-1R-binding domain of IL-1β. β-Interleukin I (163-171), human is a potent adjuvant that enhances the immune response in a variety of exptl. situations[1][3][4]. |
---|---|
Related Catalog | |
In Vitro | β-Interleukin I (163-171), human (12.5-400 μg/mL, 72 h) stimulates mouse thymocyte proliferation[6]. |
In Vivo | β-Interleukin I (163-171), human (50 μg, daily, a poorly immunogenic fibrosarcoma (CE-2) of BALB/c mice model) induces a consistent but limited inhibition of tumor growth[2]. β-Interleukin I (163-171), human (1 μmole/kg, i.v.) together with the T-dependent antigen SRBC increases the primary immune response against the antigen[3]. |
References |
Density | 1.419g/cm3 |
---|---|
Boiling Point | 1682.6ºC at 760mmHg |
Molecular Formula | C39H64N12O19 |
Molecular Weight | 1004.99000 |
Flash Point | 971.4ºC |
Exact Mass | 1004.44000 |
PSA | 540.45000 |
Vapour Pressure | 0mmHg at 25°C |
Index of Refraction | 1.573 |
Storage condition | -20°C |
WGK Germany | 3 |
---|
Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis.
Am. J. Respir. Cell. Mol. Biol. 49(1) , 47-57, (2013) Mitogen-activated protein kinase-activated protein kinase-2 (MAPKAPK2, or MK2), a serine/threonine kinase downstream of p38 mitogen-activated protein kinase, has been implicated in inflammation and fi... |
|
Tamoxifen attenuates inflammatory-mediated damage and improves functional outcome after spinal cord injury in rats.
J. Neurochem. 109(6) , 1658-67, (2009) Tamoxifen has been found to be neuroprotective in both transient and permanent experimental ischemic stroke. However, it remains unknown whether this agent shows a similar beneficial effect after spin... |
|
Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin.
Clin. J. Am. Soc. Nephrol. 1(5) , 979-86, (2006) Dialysis provides effective and safe treatment of ESRD in children, but patients who are maintained on chronic dialysis are at risk for cardiovascular disease. One major risk factor for cardiovascular... |
β-Interleukin I (163-171) |